IntroductIon
Red blood cells are an important component of the complete blood count and play a principal role in delivering oxygen (via hemoglobin) throughout the circulatory system. Abnormal red blood cell levels, which are interpreted in the context of other diagnostic results, may be indicative of various medical conditions, such as anemia (low red blood cell levels) or polycythemia (high red blood cell levels). Red blood cell distribution width (RDW) is also an important component of the complete blood count that is routinely measured during clinical assessments and provides a measure of the heterogeneity of the erythrocyte volume. A high degree of variability (eg, >14.6%) in the volume of red blood cells (ie, high RDW) may be indicative of different types of anemia and other medical conditions, providing valuable inexpensive prognostic information related to cardiovascular disease and premature mortality. [1] [2] [3] [4] Although inconclusive, the pathophysiology linking RDW with morbidity and mortality may be a result of inflammation-induced anisocytosis and/or disordered iron homeostasis, [5] [6] [7] [8] or possibly a result of cytokine-induced erythropoietin resistance. 9 There is also some evidence to suggest that sex may moderate the relationship between RDW and mortality, 10 with the need of future research examining potential ethnic effects. Although RDW is associated with increased morbidity and mortality, 1 its trend over time is unknown. Therefore, the objective of this brief study was to examine trends 
Measurement of Red Blood Cell Distribution Width
The complete blood count was from a blood sample using the Beckman Coulter MAXM analyzer. Red cell distribution width was derived from the coefficient of variation of the red cell volume distribution histogram and reported as a percent. Elevated RDW was defined as an RDW >14.6%.
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Analysis
All analyses, conducted in Stata (v. 12), took into account the complex sampling design of the surveys; sample weights (adjusted based on the combined cycles used), primary sampling units and clustering parameters were used to adjust for non-response, non-compliance and render nationally representative estimates. Mean RDW and prevalence of elevated RDW across the seven 2-year cycles was determined. Because unadjusted and age-adjusted results were similar, only the latter are reported. Age adjustments were performed using the direct method using the projected year 2000 US population aged >20 years. Tests for linear trend were conducted using linear-specific orthogonal polynomial coefficients. A two-sided P<.05 was considered statistically significant.
results
Data from 34,171 adults (≥ 20 yrs) were analyzed. The weighted mean (SE, standard error) age across the entire sample (1999-2012) was 46.7 years; the weighted proportion (SE) of women across the entire sample was 52.0%; and the weighted proportion (SE) of Whites, Blacks and Mexican Americans across the entire sample, respectively, were 70.5%, 10.7% and 7.8%. As noted in the footnote of the Tables, age, sex and race-ethnicity estimates were similar across each individual cycle.
Participants were not excluded from the analyses based on any known presence of disease. Among the analyzed 34,171 adults, 3,025 self-reported a physician diagnosis of cancer; of these 3,025 participants, the unweighted proportion (SE) across the 7 two-year cycles, respectively, were 7. 
Methods
Design
Data from seven 2-year cycles of the National Health and Nutrition Examination Survey (NHANES) were used, starting in 1999-2000 and concluding in 2011-2012 (latest available cycle). The NHANES is an ongoing survey conducted by the Centers for Disease Control and Prevention that uses a representative sample of non-institutionalized United States civilians selected by a complex, multistage, stratified, clustered probability design. Examination response rates across the survey cycles ranged from 69.5% to 79.6%. Participants provided consent to par-
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observed for men, women, nonHispanic Whites, non-Hispanic Blacks, and Mexican Americans.
The overall age-adjusted prevalence of elevated RDW increased from 4.01% in 1999-2000 to 6.25% in 2011-2012 (Table 2; Figure 1 ). Statistically significant increases in the prevalence of elevated RDW over this time period also occurred among non-Hispanic White women, non-Hispanic Black men and women, and Mexican American men and women. The largest increase in the prevalence of elevated RDW over this time period occurred among Mexican American women (4.88% increase). Notably, across all sex and race-ethnicity combinations, women, compared with men, had higher RDW and larger increases in mean and elevated RDW. Regarding men, non-Hispanic Black men had higher mean and elevated RDW across 
each time period when compared with non-Hispanic White men.
dIscussIon
Our study demonstrates that mean RDW levels and the prevalence of elevated RDW has progressively increased from 1999-2012, with this trend occurring across sex and race-ethnicity sub-groups. Notably, women had higher RDW levels and a steeper trajectory in RDW changes than men, with nonHispanic Black men having higher RDW levels (and a steeper trajectory over time) when compared with non-Hispanic White men.
This progressive increase is concerning, as higher RDW is a strong predictor of various chronic diseases 12 as well as premature mortality. 1 The biological pathways underlying the association between higher RDW and morbidity and mortality are unclear at this time. Possible mechanisms linking RDW with morbidity and mortality may be a result of inflammation, disordered iron homeostasis, and/or erythropoietin resistance-induced anisocytosis.
5-9 conclusIon
With rising health care costs, it is important to identify inexpensive biomarkers, such as RDW, which predict cardiovascular disease and premature mortality. RDW is often obtained at the time of routine physical examinations as part of the complete blood count and may provide a cost-effective way to provide incremental prognostic information. These findings support the continued routine assessment of RDW in clinical care, as well as the promotion of lifestyle factors (eg, physical activity) shown to influence RDW. [13] [14] [15] [16] Given the progressively larger increases in RDW among women, compared with men, which is supported by other work, 17 serial monitoring of RDW changes and RDW-related morbidities among women, in particular, may be needed. Given the higher RDW levels among Black men, compared with White men, careful monitoring of RDW among Black men may be needed. Future research is needed to improve our understanding of why women have higher RDW than men (observed at each time period) and why the increased trajec- 
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tory of RDW is more pronounced in women. However, future sex-specific research is needed as there is some evidence to suggest a greater magnitude of association between RDW and mortality for men compared with women. 10 Although a previous study did not observe an interaction effect of ethnicity on the RDW-mortality relationship, 10 future race-ethnicity work on this topic is warranted.
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